Advanced Medical Technologies
Advanced Medical Technologies had conventionally covered the implants, consumables, monitoring equipment, and infection prevention equipment. The sector includes all products that were the bricks and mortars of treatment and monitoring.
Today the provider, payor, and patients views of the product/ procedure have evolved. Hence, Advanced Medical Technologies not only includes the bricks and mortars of treatment and monitoring, but also the tools and solutions that improve quality of life of the patient and clinician both at care provider site and at home.
Frost & Sullivan’s Advanced Medical Technologies Research Program
At Frost & Sullivan we aim to capitalize our understanding of the transition in the industry and utilize our proven methodology that leverages Frost & Sullivan’s proprietary forecast models, access to high-quality internal and external published content, and information gained from primary research interviews to comment on the opportunities for growth across products, services and solutions for the industry participants.
With the shift towards empowering patients and the clinician in health and procedural management, we are aware that ecosystem has moved beyond medical device manufacturers to digital solutions providers, service providers, logistics providers, payors and technology companies.
The focus is on patient centric health, disease management, efficiency enabling solutions. The coverage includes patient engagement devices, hospital service solutions, digital transformation of the medical technologies industry, artificial intelligence in surgical interventions.
Frost & Sullivan’s expertise in digital health research and consulting includes work in the following strategic and operational areas:
Chronic Care Continuum
Care and Cost Optimization
Our research focus is to look at surgical ecosystem (operating rooms), critical care settings as well as service solutions, business models and technologies that would help optimize workflow and increase clinical and operational efficiency. Learn what are the new and innovative business models (such as risk sharing, e-commerce, product-as-a-service, device data utilization) that are improving margins as well as wallet share for both hospitals and OEM’s.
Our focus is to identify, evaluate and explore key technologies, services, tools and opportunities that are enabling OEM’s and hospitals to transition from traditional patient monitoring to a more holistic patient management outcome.
Book a complimentary one-hour Growth Pipeline Dialog™ session with our Healthcare & Life Sciences experts.
Greg Caressi is responsible for Frost & Sullivan’s Healthcare and Life Sciences practice, which includes Digital Health, Life Sciences, Medical Imaging & Informatics, and Advanced Medical Technologies. He engages with industry leaders across the globe regarding their technology needs and gaps, and leverages insights from our research to identify growth opportunities and needed solution capabilities for healthcare stakeholders, including healthcare providers, payors, government agencies, medical technology vendors and individual consumers.
Reenita Das currently serves as Healthcare and Life Sciences’ Partner and Senior Vice President and is the first woman Partner at Frost & Sullivan, driving the global research vision and strategy for the firm as well as commercial opportunities within the healthcare practice. She has lived and worked in over 10 countries in the world, focusing on finding solutions to healthcare challenges and implementing growth change strategies. She recently got voted the top 100 women in Femtech and Healthtech. Reenita’s focus is on how healthcare will operate 20 years from today and she shares her vision at leading conferences and events.
She is also passionate about using digital solutions and creating gender-specific healthcare by her focus on “Femtech” and the growth opportunities from this new sector which includes advising companies on the right strategies and commercial business models to success.
Dinesh Sampath Rangaraj
With more than 24 years of industry experience, Nitin serves as Frost & Sullivan’s Global Practice Area Leader (HLS). In this role, he is dedicated to executing strategy consulting, forecasting analytics, commercial due diligence and clinical R&D projects for healthcare companies.
Nitin has a strong understanding of the dynamics in the healthcare industry and possesses domain knowledge in the life sciences space. He has advised several mid sized companies and start-ups in numerous commercial transactions and IPOs to optimize market positioning and valuation strategies.
He has led strategic initiatives with Medical Device & Life Science companies:
- Emerging markets go to market strategy , Innovative therapies portfolio analysis
- Sales, Marketing, Distribution planning
- Global Alliances, Public Private Partnerships, M&A.
- Co-innovation programs, research
Charlie leads Frost & Sullivan’s growth consulting practice in the Americas supporting clients across the healthcare technology and services ecosystem. His responsibilities include project management, business development, strategic planning and subject matter expertise, particularly in the medical devices market.
Siddharth (Sid) Shah leads the global medtech research program of the Healthcare & Life Sciences practice, and has over ten years of healthcare market research & consulting experience. In his prior life he has also conducted wet lab research in stem cells at the prestigious Johns Hopkins University. Beyond medical devices, Shah also tracks innovations in radiology artificial intelligence, diabetes, and connected devices. He holds a Master of Science in Biotechnology from the Johns Hopkins University.
Daniel leads the growth consulting practice for Healthcare & Life Sciences in the Middle East & Africa. This practice covers Healthcare Delivery & Operations, Medical Imaging & Informatics, Pharmaceuticals & Life Sciences, and Digital Health.
Daniel is a seasoned healthcare professional with more than 15 years’ experience in the healthcare industry and has extensive experience supporting clients to achieve their strategic growth objectives through Optimization, Efficiency, Quality and Cost Initiatives; Market Analysis, Customer VOC/Perception studies, Due Diligence, and Service Expansion; Healthcare Data and Analytics; Change, Program and Project Management; and, Leadership Development.
Imran has over 20 years of experience in market research and consulting, covering a range of information and communication technologies across multiple industry verticals and enterprise and consumer segments.
The Medical Technologies Industry is going through a period of rapid transformation and disruption. Care is moving outside the hospital into numerous sites driven by new technology and customer engagement models.
As health systems around the world evolve to meet the challenges of access, quality and cost, we have embarked on a journey to answer the burning issues and its impact for the different stakeholders in this ecosystem.